 | • レポートコード：QFJ1-5946 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、女性健康用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（顆粒、丸薬、粉末、チンキ剤、錠剤、カプセル、その他）、用途別市場規模（閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、妊娠障害、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・女性健康用医薬品の市場動向 ・企業の競争状況、市場シェア ・女性健康用医薬品の種類別市場規模と予測2016-2027（顆粒、丸薬、粉末、チンキ剤、錠剤、カプセル、その他） ・女性健康用医薬品の用途別市場規模と予測2016-2027（閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、妊娠障害、その他） ・女性健康用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・女性健康用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性健康用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性健康用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性健康用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Lilly、Pfizer、Bayer、AbbVie、Amgen、Johnson＆Johnson） ・結論 |
Pharmaceuticals for Women’s Health is the generic name for specific diseases such as postmenopausal osteoporosis, endometriosis, polycystic ovary syndrome, pregnancy disorders, etc.
Market Analysis and Insights: Global Pharmaceuticals for Women’s Health Market
The global Pharmaceuticals for Women’s Health market size is projected to reach US$ 31810 million by 2027, from US$ 26160 million in 2020, at a CAGR of 2.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceuticals for Women’s Health market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceuticals for Women’s Health market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceuticals for Women’s Health market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceuticals for Women’s Health market.
Global Pharmaceuticals for Women’s Health Scope and Market Size
Pharmaceuticals for Women’s Health market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceuticals for Women’s Health market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Granules
Pills
Powder
Tincture
Tablets
Capsule
Other
Segment by Application
Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovarian Syndrome
Pregnancy Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Lilly
Pfizer
Bayer
AbbVie
Amgen
Johnson＆Johnson
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceuticals for Women’s Health Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Granules
1.2.3 Pills
1.2.4 Powder
1.2.5 Tincture
1.2.6 Tablets
1.2.7 Capsule
1.2.8 Other
1.3 Market by Application
1.3.1 Global Pharmaceuticals for Women’s Health Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Postmenopausal Osteoporosis
1.3.3 Endometriosis
1.3.4 Polycystic Ovarian Syndrome
1.3.5 Pregnancy Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceuticals for Women’s Health Market Perspective (2016-2027)
2.2 Pharmaceuticals for Women’s Health Growth Trends by Regions
2.2.1 Pharmaceuticals for Women’s Health Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceuticals for Women’s Health Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceuticals for Women’s Health Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceuticals for Women’s Health Industry Dynamic
2.3.1 Pharmaceuticals for Women’s Health Market Trends
2.3.2 Pharmaceuticals for Women’s Health Market Drivers
2.3.3 Pharmaceuticals for Women’s Health Market Challenges
2.3.4 Pharmaceuticals for Women’s Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceuticals for Women’s Health Players by Revenue
3.1.1 Global Top Pharmaceuticals for Women’s Health Players by Revenue (2016-2021)
3.1.2 Global Pharmaceuticals for Women’s Health Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceuticals for Women’s Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceuticals for Women’s Health Revenue
3.4 Global Pharmaceuticals for Women’s Health Market Concentration Ratio
3.4.1 Global Pharmaceuticals for Women’s Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals for Women’s Health Revenue in 2020
3.5 Pharmaceuticals for Women’s Health Key Players Head office and Area Served
3.6 Key Players Pharmaceuticals for Women’s Health Product Solution and Service
3.7 Date of Enter into Pharmaceuticals for Women’s Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceuticals for Women’s Health Breakdown Data by Type
4.1 Global Pharmaceuticals for Women’s Health Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceuticals for Women’s Health Forecasted Market Size by Type (2022-2027)
5 Pharmaceuticals for Women’s Health Breakdown Data by Application
5.1 Global Pharmaceuticals for Women’s Health Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceuticals for Women’s Health Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceuticals for Women’s Health Market Size (2016-2027)
6.2 North America Pharmaceuticals for Women’s Health Market Size by Type
6.2.1 North America Pharmaceuticals for Women’s Health Market Size by Type (2016-2021)
6.2.2 North America Pharmaceuticals for Women’s Health Market Size by Type (2022-2027)
6.2.3 North America Pharmaceuticals for Women’s Health Market Size by Type (2016-2027)
6.3 North America Pharmaceuticals for Women’s Health Market Size by Application
6.3.1 North America Pharmaceuticals for Women’s Health Market Size by Application (2016-2021)
6.3.2 North America Pharmaceuticals for Women’s Health Market Size by Application (2022-2027)
6.3.3 North America Pharmaceuticals for Women’s Health Market Size by Application (2016-2027)
6.4 North America Pharmaceuticals for Women’s Health Market Size by Country
6.4.1 North America Pharmaceuticals for Women’s Health Market Size by Country (2016-2021)
6.4.2 North America Pharmaceuticals for Women’s Health Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceuticals for Women’s Health Market Size (2016-2027)
7.2 Europe Pharmaceuticals for Women’s Health Market Size by Type
7.2.1 Europe Pharmaceuticals for Women’s Health Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceuticals for Women’s Health Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceuticals for Women’s Health Market Size by Type (2016-2027)
7.3 Europe Pharmaceuticals for Women’s Health Market Size by Application
7.3.1 Europe Pharmaceuticals for Women’s Health Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceuticals for Women’s Health Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceuticals for Women’s Health Market Size by Application (2016-2027)
7.4 Europe Pharmaceuticals for Women’s Health Market Size by Country
7.4.1 Europe Pharmaceuticals for Women’s Health Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceuticals for Women’s Health Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceuticals for Women’s Health Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Type
8.2.1 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Application
8.3.1 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Region
8.4.1 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceuticals for Women’s Health Market Size (2016-2027)
9.2 Latin America Pharmaceuticals for Women’s Health Market Size by Type
9.2.1 Latin America Pharmaceuticals for Women’s Health Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceuticals for Women’s Health Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceuticals for Women’s Health Market Size by Type (2016-2027)
9.3 Latin America Pharmaceuticals for Women’s Health Market Size by Application
9.3.1 Latin America Pharmaceuticals for Women’s Health Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceuticals for Women’s Health Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceuticals for Women’s Health Market Size by Application (2016-2027)
9.4 Latin America Pharmaceuticals for Women’s Health Market Size by Country
9.4.1 Latin America Pharmaceuticals for Women’s Health Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceuticals for Women’s Health Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceuticals for Women’s Health Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Type
10.2.1 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Application
10.3.1 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Country
10.4.1 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Pharmaceuticals for Women’s Health Introduction
11.1.4 Allergan Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Lilly
11.2.1 Lilly Company Details
11.2.2 Lilly Business Overview
11.2.3 Lilly Pharmaceuticals for Women’s Health Introduction
11.2.4 Lilly Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.2.5 Lilly Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pharmaceuticals for Women’s Health Introduction
11.3.4 Pfizer Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pharmaceuticals for Women’s Health Introduction
11.4.4 Bayer Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Pharmaceuticals for Women’s Health Introduction
11.5.4 AbbVie Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Pharmaceuticals for Women’s Health Introduction
11.6.4 Amgen Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Company Details
11.7.2 Johnson＆Johnson Business Overview
11.7.3 Johnson＆Johnson Pharmaceuticals for Women’s Health Introduction
11.7.4 Johnson＆Johnson Revenue in Pharmaceuticals for Women’s Health Business (2016-2021)
11.7.5 Johnson＆Johnson Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Granules
Table 3. Key Players of Pills
Table 4. Key Players of Powder
Table 5. Key Players of Tincture
Table 6. Key Players of Tablets
Table 7. Key Players of Capsule
Table 8. Key Players of Other
Table 9. Global Pharmaceuticals for Women's Health Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Pharmaceuticals for Women's Health Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Pharmaceuticals for Women's Health Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Pharmaceuticals for Women's Health Market Share by Regions (2016-2021)
Table 13. Global Pharmaceuticals for Women's Health Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Pharmaceuticals for Women's Health Market Share by Regions (2022-2027)
Table 15. Pharmaceuticals for Women's Health Market Trends
Table 16. Pharmaceuticals for Women's Health Market Drivers
Table 17. Pharmaceuticals for Women's Health Market Challenges
Table 18. Pharmaceuticals for Women's Health Market Restraints
Table 19. Global Pharmaceuticals for Women's Health Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Pharmaceuticals for Women's Health Market Share by Players (2016-2021)
Table 21. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals for Women's Health as of 2020)
Table 22. Ranking of Global Top Pharmaceuticals for Women's Health Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Pharmaceuticals for Women's Health Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Pharmaceuticals for Women's Health Product Solution and Service
Table 26. Date of Enter into Pharmaceuticals for Women's Health Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pharmaceuticals for Women's Health Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2016-2021)
Table 30. Global Pharmaceuticals for Women's Health Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Pharmaceuticals for Women's Health Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Pharmaceuticals for Women's Health Revenue Market Share by Application (2016-2021)
Table 34. Global Pharmaceuticals for Women's Health Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Pharmaceuticals for Women's Health Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Pharmaceuticals for Women's Health Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Pharmaceuticals for Women's Health Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Pharmaceuticals for Women's Health Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Pharmaceuticals for Women's Health Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Pharmaceuticals for Women's Health Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Pharmaceuticals for Women's Health Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceuticals for Women's Health Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Pharmaceuticals for Women's Health Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Pharmaceuticals for Women's Health Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Pharmaceuticals for Women's Health Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Pharmaceuticals for Women's Health Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Pharmaceuticals for Women's Health Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceuticals for Women's Health Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Pharmaceuticals for Women's Health Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Pharmaceuticals for Women's Health Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Pharmaceuticals for Women's Health Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Pharmaceuticals for Women's Health Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Pharmaceuticals for Women's Health Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Country (2022-2027) & (US$ Million)
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Pharmaceuticals for Women's Health Product
Table 69. Allergan Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Lilly Company Details
Table 72. Lilly Business Overview
Table 73. Lilly Pharmaceuticals for Women's Health Product
Table 74. Lilly Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 75. Lilly Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Pharmaceuticals for Women's Health Product
Table 79. Pfizer Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Pharmaceuticals for Women's Health Product
Table 84. Bayer Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 85. Bayer Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Pharmaceuticals for Women's Health Product
Table 89. AbbVie Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Pharmaceuticals for Women's Health Product
Table 94. Amgen Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 95. Amgen Recent Development
Table 96. Johnson＆Johnson Company Details
Table 97. Johnson＆Johnson Business Overview
Table 98. Johnson＆Johnson Pharmaceuticals for Women's Health Product
Table 99. Johnson＆Johnson Revenue in Pharmaceuticals for Women's Health Business (2016-2021) & (US$ Million)
Table 100. Johnson＆Johnson Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceuticals for Women's Health Market Share by Type: 2020 VS 2027
Figure 2. Granules Features
Figure 3. Pills Features
Figure 4. Powder Features
Figure 5. Tincture Features
Figure 6. Tablets Features
Figure 7. Capsule Features
Figure 8. Other Features
Figure 9. Global Pharmaceuticals for Women's Health Market Share by Application: 2020 VS 2027
Figure 10. Postmenopausal Osteoporosis Case Studies
Figure 11. Endometriosis Case Studies
Figure 12. Polycystic Ovarian Syndrome Case Studies
Figure 13. Pregnancy Disorders Case Studies
Figure 14. Others Case Studies
Figure 15. Pharmaceuticals for Women's Health Report Years Considered
Figure 16. Global Pharmaceuticals for Women's Health Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Pharmaceuticals for Women's Health Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Pharmaceuticals for Women's Health Market Share by Regions: 2020 VS 2027
Figure 19. Global Pharmaceuticals for Women's Health Market Share by Regions (2022-2027)
Figure 20. Global Pharmaceuticals for Women's Health Market Share by Players in 2020
Figure 21. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals for Women's Health as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Pharmaceuticals for Women's Health Revenue in 2020
Figure 23. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2016-2021)
Figure 24. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2022-2027)
Figure 25. North America Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Pharmaceuticals for Women's Health Market Share by Type (2016-2027)
Figure 27. North America Pharmaceuticals for Women's Health Market Share by Application (2016-2027)
Figure 28. North America Pharmaceuticals for Women's Health Market Share by Country (2016-2027)
Figure 29. United States Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Pharmaceuticals for Women's Health Market Share by Type (2016-2027)
Figure 33. Europe Pharmaceuticals for Women's Health Market Share by Application (2016-2027)
Figure 34. Europe Pharmaceuticals for Women's Health Market Share by Country (2016-2027)
Figure 35. Germany Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Pharmaceuticals for Women's Health Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Pharmaceuticals for Women's Health Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Pharmaceuticals for Women's Health Market Share by Region (2016-2027)
Figure 45. China Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Pharmaceuticals for Women's Health Market Share by Type (2016-2027)
Figure 53. Latin America Pharmaceuticals for Women's Health Market Share by Application (2016-2027)
Figure 54. Latin America Pharmaceuticals for Women's Health Market Share by Country (2016-2027)
Figure 55. Mexico Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Pharmaceuticals for Women's Health Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Pharmaceuticals for Women's Health Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Pharmaceuticals for Women's Health Market Share by Country (2016-2027)
Figure 61. Turkey Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Pharmaceuticals for Women's Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Allergan Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 65. Lilly Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 68. AbbVie Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 70. Johnson＆Johnson Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
女性健康用医薬品のグローバル市場：規模・現状・予測2019-2025 Pharmaceuticals for Women's Health is the generic name for specific diseases such as postmenopausal osteoporosis, endometriosis, polycystic ovary syndrome, pregnancy disorders, etc.In 2018, the global Pharmaceuticals for Women's Health market size was xx million US$ and it is expected to reach xx mi…- 女性健康用医薬品のグローバル市場：規模・現状・予測2019-2025 Pharmaceuticals for Women's Health is the generic name for specific diseases such as postmenopausal osteoporosis, endometriosis, polycystic ovary syndrome, pregnancy disorders, etc.In 2018, the global Pharmaceuticals for Women's Health market size was xx million US$ and it is expected to reach xx mi…
- 世界の女性用医薬品市場規模・現状・予測（2021年-2027年） Drugs specialized for women's health. Market Analysis and Insights: Global Women's Health Care Drugs Market The global Women's Health Care Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
- 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場規模・現状・予測（2021年-2027年） Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. Market Analysis and Insights: Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market The global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size is projected to reach …
- 世界の女性用医療機器市場規模・現状・予測（2021年-2027年） Women health refers to the health of women, which differs from that of men in many unique ways. Market Analysis and Insights: Global Women Health Devices Market The global Women Health Devices market size is projected to reach US$ 31880 million by 2027, from US$ 23920 million in 2020, at a CAGR of 3…